Table 1.
Clinical characteristics of breast cancer patients.
| Characteristic | Low expression of TIMM8A | High expression of TIMM8A | p |
|---|---|---|---|
| n | 541 | 542 | |
| T stage, n (%) | 0.016 | ||
| T1 | 155 (14.4%) | 122 (11.3%) | |
| T2 | 295 (27.3%) | 334 (30.9%) | |
| T3 | 77 (7.1%) | 62 (5.7%) | |
| T4 | 13 (1.2%) | 22 (2%) | |
| N stage, n (%) | 0.455 | ||
| N0 | 258 (24.2%) | 256 (24.1%) | |
| N1 | 185 (17.4%) | 173 (16.3%) | |
| N2 | 50 (4.7%) | 66 (6.2%) | |
| N3 | 38 (3.6%) | 38 (3.6%) | |
| M stage, n (%) | 0.162 | ||
| M0 | 436 (47.3%) | 466 (50.5%) | |
| M1 | 6 (0.7%) | 14 (1.5%) | |
| PR status, n (%) | < 0.001 | ||
| Negative | 114 (11%) | 228 (22.1%) | |
| Indeterminate | 2 (0.2%) | 2 (0.2%) | |
| Positive | 402 (38.9%) | 286 (27.7%) | |
| ER status, n (%) | < 0.001 | ||
| Negative | 61 (5.9%) | 179 (17.3%) | |
| Indeterminate | 0 (0%) | 2 (0.2%) | |
| Positive | 457 (44.2%) | 336 (32.5%) | |
| HER2 status, n (%) | 0.014 | ||
| Negative | 292 (40.2%) | 266 (36.6%) | |
| Indeterminate | 4 (0.6%) | 8 (1.1%) | |
| Positive | 63 (8.7%) | 94 (12.9%) | |
| Age, n (%) | 0.120 | ||
| <=60 | 287 (26.5%) | 314 (29%) | |
| >60 | 254 (23.5%) | 228 (21.1%) | |
| OS event, n (%) | < 0.001 | ||
| Alive | 485 (44.8%) | 446 (41.2%) | |
| Dead | 56 (5.2%) | 96 (8.9%) |